References
Boeckh M, Nichols WG, Papanicolaou G et al (2003) Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 9:543–558
Eid AJ, Razonable RR (2010) New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs 70:965–981
Torres HA, Kontoyiannis DP, Aguilera EA et al (2006) Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6:393–398
Matthew Rong Jie T, Soon Thye L et al (2014) Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leuk Lymphoma 55(1):182–187
Mitsumori T, Sueki Y et al (2014) Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy. Rinsho Ketsueki 55(2):239–243
Rummel MJ, Al-Batran SE, Kim SZ et al (2005) Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin’s lymphoma. J Clin Oncol 2:3383–3389
Kahl BS, Bartlett NL, Leonard JP et al (2010) Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non- Hodgkin lymphoma: results from a Multicenter Study. Cancer 116:106–114
Lim SH, Pathapati S, Langevin J, Hoot A (2012) Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine. Ann Hematol 91:643–644
Hosoda T, Yokoyama A et al (2013) Bendamustine can severely impair T-cell immunity against cytomegalovirus. Leuk Lymphoma 54:1327–1328
Takeda N et al (2001) Studies of Anti-Cytomegalovirus IgG antibody positive rate and cytomegalovirus mononucleosis in adults. Kansensho 75:775–779
Conflict of interest
The authors have no financial support or relationships that may pose conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasegawa, T., Aisa, Y., Shimazaki, K. et al. Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma. Ann Hematol 94, 515–517 (2015). https://doi.org/10.1007/s00277-014-2182-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2182-1